Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to advance the science of scale-up and sustainment of lung cancer screening (LCS) for populations at high risk for lung cancer.
This NOFO will support studies that will identify the most effective implementation
credit:
strategies for scaling-up and sustaining the delivery of LCS across a range of clinical care settings and diverse populations at high risk for lung cancer.
This NOFO will use the UG3/UH3 phased cooperative agreement mechanism.
The UG3 phase will support preparatory activities for the scale-up and sustainment trial.
The UH3 phase will support the scale-up and sustainment trial.